Gene:
ALOX5
arachidonate 5-lipoxygenase

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

To see more Clinical Variants with lower levels of criteria, click the button at the bottom of the table.

Position ? Drug ? Relevance ? Strength of
Evidence ?
rs2115819 more likely to work 3
rs2115819 more likely to work 3

Download a summary of all Clinical Annotations available.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

Variant?
(build 132)
Alternate Names ? Drugs ? Alleles ? Function ? Amino Acid?
Translation
VIP No Clinical Annotations available No Variant Annotations available
chr10:45869552
rs2115819 c.432-6550A>G, g.3546154A>G, g.36461A>G, rs2115819 G/A Intronic
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP build 132

Overview

Alternate Names:  5-lipoxygenase; OTTHUMP00000019502; arachidonic acid 5-lipoxygenase; leukotriene A4 synthase
Alternate Symbols:  5-LO; 5-LOX; 5LPG; LOG5; MGC163204
PharmGKB Accession Id: PA46

Details

Cytogenetic Location: chr10 : q11.21 - q11.21
GP mRNA Boundary: chr10 : 45869629 - 45941565
GP Gene Boundary: chr10 : 45859629 - 45944565
Strand: plus
Product Name: arachidonate 5-lipoxygenase, arachidonic acid 5-lipoxygenase, leukotriene A4 synthase
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

External Pathways

Links to non-PharmGKB pathways.

  1. eicosanoid metabolism - (BioCarta via Pathway Interaction Database)
  2. Leukotriene synthesis - (Reactome via Pathway Interaction Database)

No related genes are available.

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other genes is available.

Curated Information ?

Drug Class Relationship Evidence
alox5-pathway modifiers
  •   
  •   
Publications
glucocorticoids
  •   
  •   
Publications
Leukotriene receptor antagonists
  • PD
  • PK
Publications
xenobiotics
  •   
  •   
Publications
Drug Relationship Evidence
montelukast
  • PD
  •   
Publications, Pathways, Variants
pranlukast
  • PD
  •   
Pathways
zafirlukast
  • PD
  •   
Publications, Pathways
zileuton
  • PD
  •   
Publications, Pathways

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information ?

Disease Relationship Evidence
Alzheimer Disease
  •   
  •   
Publications
Arteriosclerosis
  •   
  •   
Publications
Asthma
  • PD
  • PK
Publications, Variants
Precursor Cell Lymphoblastic Leukemia-Lymphoma
  •   
  •   
Publications
Rhinitis, Allergic, Perennial
  •   
  •   
Publications
Rhinitis, Allergic, Seasonal
  •   
  •   
Publications

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other diseases is available.

Downloads

You must sign in before you can download data.

LinkOuts

Entrez Gene:
240
OMIM:
152390
600807
UCSC Genome Browser:
NM_000698
RefSeq RNA:
NM_000698
RefSeq Protein:
NP_000689
RefSeq DNA:
AC_000053
AC_000142
NC_000010
NG_011437
NT_033985
NW_001837940
NW_921506
NW_924606
UniProtKB:
LOX5_HUMAN (P09917)
Ensembl:
ENSG00000012779
GenAtlas:
ALOX5
GeneCard:
GC10P045869 (240)
SOURCE:
ALOX5
MutDB:
ALOX5
ALFRED:
LO037847D
HuGE:
ALOX5
Comparative Toxicogenomics Database:
240
ModBase:
P09917
HumanCyc Gene:
HS00336
HGNC:
435

Common Searches

Non-Curated Publications

A list of non-curated publications that mention this gene is available.

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.